John Sholar Email

CEO . jCyte

Newport Beach, CA

Location

Current Roles

Employees:
13
Revenue:
$2M
About
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
jCyte Address
23 Corporate Plaza Dr.
Newport Beach, CA
United States
jCyte Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.